This 2723-female infant was born at 35 weeks' gestation to a 28-year-old gravida 3, para 0 mother. The pregnancy was complicated by type 1 insulin-dependent diabetes of 16 years' duration. The mother's hemoglobin A1c was measured throughout the pregnancy and ranged from 5.9% to 7.5%. She was normotensive during the entire pregnancy. The membranes were ruptured 13 hours before delivery and the infant was delivered vaginally with vacuum assistance. Apgar scores were 5 and 7 at 1 and 5 minutes, respectively. At delivery, it was noted that the infant was born with a malformed, necrotic left leg below the knee (Figure 1 ). The fibula was dislocated and extruding through the gangrenous skin. The patient underwent a below the knee amputation at 3 hours of age. Blood and wound cultures were negative. Pathologic examination confirmed ischemic necrosis of the lower leg including skin, soft tissue, muscle, cartilage, and bone. The arteries were thick walled with varying amounts of intimal proliferation and/or recanalization consistent with previous thrombosis (Figure 2 ). There were also microscopic foci of dystrophic calcification in small vessels. The arterial changes may have occurred as recently as 2 weeks before delivery; however, there was a loss of nuclear staining in the skeletal muscle and bone and the foot length was only 3.5 cm. This suggests that the ischemic event occurred at approximately 22 to 24 weeks' gestation. The rest of the infant's physical exam was normal. She was the appropriate size for her gestational age. There was no physical evidence of a renal vein thrombus.
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The patient began having apneic episodes with desaturations on the second postoperative day. A CT scan of the head revealed a small right thalamic infarct with intraventricular and periventricular blood. There was no evidence of a sagittal sinus thrombus. Magnetic resonance imaging confirmed these findings. An abdominal ultrasound revealed increased echogenicity in the right lobe of the liver, which was suggestive of a hepatic infarct. There was also a right adrenal hemorrhage. No evidence of a thrombus could be identified in the renal veins or inferior vena cava. An abdominal CT scan at 4 weeks of age showed near-complete resolution of the liver lesion and adrenal hemorrhage.
Because of the ischemic necrosis of the lower leg, with thalamic and hepatic infarcts, the infant had an evaluation for thrombophilia ( Table 1 ). The anticardiolipin IgG was positive in the mother (34.8 GPL), but there were insignificant levels in the infant. Both mother and infant were negative for anticardiolipin IgM. The mother's antinuclear antibody was negative. Homocysteine was <2.5 mol/l in the infant and the factor V Leiden mutation was not detected.
DISCUSSION
The increased incidence of thrombosis in infants of diabetic mothers (IDMs) has been well recognized. In the majority of previously reported cases, a renal vein thrombus served as the source of embolization. Emboli dislodged from the renal vein or inferior vena cava are carried through the venous circulation to the right atrium. These emboli progress through the foramen ovale into the left side of the heart and ascending aorta. Before birth, blood flow from this source preferentially supplies the head and upper extremities. Therefore, most previous reports of extremity gangrene in IDMs have involved embolization from the renal vein to the upper extremities. 1 -4 This case report is of an infant of a diabetic mother who presented with lower extremity gangrene occurring in utero that necessitated a below the knee amputation at 3 hours of age. The association of venous thrombi in infants of diabetic mothers ( IDMs ) has been firmly established. However, in this case the thrombi were arterial and resulted in gangrene during the second trimester of gestation. The reason for the increased tendency to develop thrombi in infant of diabetic mothers has not been elucidated. We did an extensive workup of this infant to look for a cause of the arterial thrombus. The only abnormality found was in the plasminogen activity, which was significantly lower than the reference values for infants of the same gestational and chronological age. The significance of this finding on the propensity of IDMs to develop thrombi is discussed. Perinatal/Neonatal Case Presentation
In contrast, the patient reported here had gangrene of the lower extremity without an associated renal vein thrombus. There is one other report of an IDM who presented at birth with a clinical examination consistent with occlusion of the brachial or axillary artery without an associated venous thrombus. 5 Thrombi from the placenta may be the source of emboli in those IDM patients without associated renal vein thrombi. In a clinicopathologic correlation analyzing the association between placental thrombi and somatic thrombi in the fetus, autopsy findings demonstrated that 37.5% of fetuses with significant placental thrombi had associated somatic thrombi. 6 The fetal lesions were found in the brain, lungs, and kidneys. Unfortunately, the placenta in this case report was discarded before the pathology review.
The patient reported here was distinctive in the timing of the vascular occlusion. The pathologist consulted about the amputated limb in this infant indicated that the occlusion most likely occurred between 22 and 24 weeks' gestation. Extremity gangrene in neonates born to diabetic and nondiabetic women has been attributed to complications of delivery such as prolapse of the affected limb between the head and uterine wall, prolonged rupture of membranes, or a ''dry'' difficult labor. Approximately half of the cases present on the first day of life, 7 but did not present with evidence of prolonged in utero thrombosis.
Although the majority of reported neonates with early limb ischemia have been IDMs, the mechanism for their propensity to form thrombi has not been established. Previous reports of IDMs with vascular thrombi limited the evaluation of a coagulation disorder to prothrombin time and activated partial thrombopolastin time. In this case, we did an extensive work up to evaluate the infant for thrombophilia ( Table 1 ). The development of thrombosis within the vasculature depends on the balance between procoagulant and antithrombotic factors and the balance between activators and inhibitors of fibrinolysis. Fibrinolysis is mediated by plasmin, the enzymatically active form of plasminogen. Plasminogen is converted to plasmin by tissue plasminogen activator (TPA) and urokinase plasminogen activator. In the patient reported here, the plasminogen activity was significantly less than the lower 95th percentile confidence limit for a 30 to 36 weeks' gestation infant at 3 days of age. The assay for plasminogen activity was performed using streptokinase to convert the plasminogen in the serum sample to plasmin. The activity was then quantified by using the plasmin substrate N -CBZ-L-lysine p-nitrophenyl ester, as previously described. 8 The role of decreased plasminogen activity in the pathogenesis of venous thromboembolism has been debated in the literature. In a cohort of 1192 adult patients with a history or family history of venous and/or arterial thromboembolism, plasminogen deficiency was found in only 1.9%. In family members of the propositi, thrombotic events were equally frequent in the plasminogendeficient and nondeficient subjects. 9 In a second report of two unrelated Japanese women with thrombi and plasminogen levels 50% of normal, their relatives with 50% normal plasminogen activity did not uniformly have an increased risk of developing thrombotic disease. 10 In both of the above reports, the majority of patients with plasminogen deficiency and thrombosis had a second risk factor that predisposed them to thrombotic events. The decrease in plasminogen activity alone was not thrombotic. The plasminogen activity in the infant described here was markedly decreased compared to neonates of similar gestation and age whose plasminogen activity is already 50% less than that of normal adults. 11 Therefore, our infant's activity was appreciably less than that of heterozygous adults with congenital plasminogen deficiency (described in the above studies) whose thrombophilia was variable. Perhaps in this infant the decrease in plasminogen activity alone was sufficient to result in thrombi formation.
In this case report, the only risk factor for thrombus formation other than the decreased plasminogen activity was the elevated anticardiolipin IgG noted in the baby's mother. Maternal anticardiolipin antibodies are associated with venous or arterial thrombosis in the mother, preeclampsia, intrauterine growth restriction, and fetal death. 12 In this case report, neither the mother nor the infant had features commonly seen in anticardiolipin syndrome. The mother was not hypertensive during the pregnancy and the infant did not have evidence of in utero growth retardation. Maternal anticardiolipin antibodies generally predispose the mother to thrombosis and do not result in fetal or neonatal thrombosis. The proposed mechanism for thrombus formation is that anticardiolipin binds to phospholipids on the platelet surface causing platelet agglutination that is followed by fibrin formation. 13 The complications in the fetus are related to placental vessel thrombosis. There is one case report of thrombosis in a neonate whose mother had anticardiolipin antibodies. The infant had thrombi in the renal vein and inferior vena cava. In that case, there was a 2-year history of maternal lupus, positive antinuclear antibody, a high titer of maternal anticardiolipin IgG and a moderate level of neonatal anticardiolipin IgG. 14 In the infant reported here, the mother's antinuclear antibody was negative, the maternal IgG titer to cardiolipin was not markedly elevated, and the infant did not have anticardiolipin in her serum. However, because the mother reported here did have anticardiolipin in her serum, thrombi from the placenta may have embolized to the fetus and caused the arterial thrombi our patient.
In our literature review, IDMs with thrombi and associated ischemic changes had minimal clotting studies done postnatally. Assays looking for abnormalities in clot formation and fibrinolysis would be very informative in subsequent IDMs with neonatal thrombosis. In light of this report, these infants should have plasminogen activity checked to determine if the association of low plasminogen activity in IDMs with thrombi is substantiated. In addition, any infant who presents with a thrombus that occurred in utero or shortly after delivery should have a pathologic exam of the placenta. From this case report and one other it is evident that not all Long and Lorant In Utero Gangrene in an Infant of a Diabetic Mother
